Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

496 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MEN16132, a novel potent and selective nonpeptide kinin B2 receptor antagonist: in vivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs.
Valenti C, Cialdai C, Giuliani S, Lecci A, Tramontana M, Meini S, Quartara L, Maggi CA. Valenti C, et al. Among authors: giuliani s. J Pharmacol Exp Ther. 2005 Nov;315(2):616-23. doi: 10.1124/jpet.105.088252. Epub 2005 Jul 18. J Pharmacol Exp Ther. 2005. PMID: 16027229
MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
Cucchi P, Meini S, Bressan A, Catalani C, Bellucci F, Santicioli P, Lecci A, Faiella A, Rotondaro L, Giuliani S, Giolitti A, Quartara L, Maggi CA. Cucchi P, et al. Among authors: giuliani s. Eur J Pharmacol. 2005 Dec 28;528(1-3):7-16. doi: 10.1016/j.ejphar.2005.10.014. Epub 2005 Dec 1. Eur J Pharmacol. 2005. PMID: 16324696
MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Cialdai C, Tramontana M, Patacchini R, Lecci A, Catalani C, Catalioto RM, Meini S, Valenti C, Altamura M, Giuliani S, Maggi CA. Cialdai C, et al. Among authors: giuliani s. Eur J Pharmacol. 2006 Nov 7;549(1-3):140-8. doi: 10.1016/j.ejphar.2006.08.021. Epub 2006 Aug 26. Eur J Pharmacol. 2006. PMID: 16979621
Pharmacological characterization of the bradykinin B2 receptor antagonist MEN16132 in rat in vitro bioassays.
Meini S, Cucchi P, Catalani C, Bellucci F, Giuliani S, Santicioli P, Maggi CA. Meini S, et al. Among authors: giuliani s. Eur J Pharmacol. 2009 Aug 1;615(1-3):10-6. doi: 10.1016/j.ejphar.2009.04.057. Epub 2009 May 13. Eur J Pharmacol. 2009. PMID: 19445925
In these assays MEN16132 (pK(B): 9.7 both in uterus and bladder) was about 10-fold more potent than icatibant [pK(B): 8.8 in uterus, and pK(B) 8.0 in urinary bladder, as from Meini, S., Patacchini, R., Giuliani, S., Lazzeri, M., Turini, D., Maggi, C.A., Lecci …
In these assays MEN16132 (pK(B): 9.7 both in uterus and bladder) was about 10-fold more potent than icatibant [pK(B): 8.8 in uterus, and pK( …
Effect of Intra-articular 4-(S)-amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido]-tetrahydro-2H-4-pyranylcarbonyl} piperazino)-5-oxopentyl](trimethyl)ammonium chloride hydrochloride (MEN16132), a kinin B2 receptor antagonist, on nociceptive response in monosodium iodoacetate-induced experimental osteoarthritis in rats.
Cialdai C, Giuliani S, Valenti C, Tramontana M, Maggi CA. Cialdai C, et al. Among authors: giuliani s. J Pharmacol Exp Ther. 2009 Dec;331(3):1025-32. doi: 10.1124/jpet.109.159657. Epub 2009 Sep 10. J Pharmacol Exp Ther. 2009. PMID: 19745108
496 results